Ypsomed Logo
  • English
  • Deutsch
 
Group Ypsomed Websites
  • Group
  • Australia
  • Austria
  • Belgium
  • Canada
  • China
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Niederlands
  • Norway
  • Poland
  • Spain
  • Sweden
  • United Kingdom
 
Skip navigation
  • Company
    • Vision - Mission - Strategy
    • Group structure
    • Management team
    • Sustainability & Social Responsibility
      • Human Resources Policy
      • Environment
      • Disclosure of grants
      • Lean Management
      • Risk management
    • YpsoStories
    • Our Employees
    • History
    • Suppliers
    • Contact
      • Subsidiaries and Distributors
  • Delivery Systems
  • Diabetes Care
  • Jobs & Careers
    • Vacant Positions
      • Professionals
      • Job beginners
      • Apprenticeships
      • For recruitment agencies
    • Working for Ypsomed
      • Career and continuing professional development
      • Programmes for employee development
      • Quality of life
      • Working conditions and benefits
    • Apprenticeship
      • Training conditions at Ypsomed
    • Recruiting Events
  • Media & Investors
    • Facts & Figures
    • Press releases
      • News Service
      • Image gallery
    • Financial calendar
    • Annual General Meeting
    • Reports
      • Order printed reports
    • Presentations
    • Shares
      • Financial analysts coverage
      • Share key data
      • Dividend
    • Corporate Governance
      • Code of Conduct
 

YDS Newsletter

Latest News Press Releases

02.10.2020
World's first zero carbon emission autoinjector from Ypsomed

Read more … World's first zero carbon emission autoinjector from Ypsomed

02.07.2020
Ypsomed’s Annual General Meeting approves all proposals and elects Gilbert Achermann as a new member of the Board of Directors

Read more … Ypsomed’s Annual General Meeting approves all proposals and elects Gilbert Achermann as a new member of the Board of Directors

27.05.2020
Ypsomed grows strongly in pharma customer business and continues to invest in the market development of the insulin pump

Read more … Ypsomed grows strongly in pharma customer business and continues to invest in the market development of the insulin pump

TOP
Skip navigation
  • Imprint
  • Terms of service
  • Data privacy
  • Cookie Policy
  • Quality certificates
 
Skip navigation
  • Suppliers
  • Opening hours for goods delivery
  • Subsidiaries and distributors
  • Contact us
  • Sitemap
 

Contact

Ypsomed AG
Headquarters Burgdorf
Brunnmattstrasse 6
3401 Burgdorf
Switzerland

T +41 (0)34 424 41 11
F +41 (0)34 424 41 22
info@ypsomed.com

Follow us on
Page last update: 10/01/2020 - 2:20pm © by
Ypsomed Logo